Literature DB >> 4155220

Abnormal involuntary movements induced by anticholinergic therapy.

E Birket-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4155220     DOI： 10.1111/j.1600-0404.1974.tb02820.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  14 in total

1.  The management of neuroleptic-induced CNS effects.

Authors:  B F Hoffman; M V Seeman
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

Review 2.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

3.  Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.

Authors:  G Chouinard; D Boisvert; J Bradwejn
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

Review 4.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.

Authors:  J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

Review 6.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 7.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

8.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

9.  Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.

Authors:  R J Carey; J De Veaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity.

Authors:  L A Marco; R S Joshi; C Brown; L D Aldes; R B Chronister
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.